E. coli strain found in NYC hospital

Researchers identified a highly resistant strain of Escherichia coli in four patients


Researchers identified a highly resistant strain of Escherichia coli in four patients at a hospital in New York City, according to an article on the Becker's Clinical Leadership & Infection Control.

A study published in Antimicrobial Agents and Chemotherapy said researchers identified the bacteria while monitoring patients with weakened immune systems.

Three of the patients exhibited no symptoms, which increases the risk of unknowingly spreading the bacteria.

While the strain has been described from other parts of the world, it has been very rare in the U.S, according to an author of the study.

Read the article.



April 17, 2019


Topic Area: Infection Control


Recent Posts

Small Details, Real Impact: Design With Caregivers in Mind

Healthcare facility designers do not practice medicine, but their work is still a meaningful way to help those who provide patient care.


Safety Features Senior Living Communities Prioritize

Families want their loved one to be in a safe facility, leading designers to prioritize more safety features.


Cherry Health Reports Data Breach Incident

It presently has no evidence that any such information has been used to commit identity theft or fraud.


Avoiding Mistakes in Healthcare Site Selection

Actionable strategies for healthcare systems and medical groups navigating today’s constrained real estate market.


Can Rural Hospitals Be Saved?

More than 700 rural hospitals nationwide face the risk of closure. A new report highlights solutions that could improve long-term sustainability.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.